| Investor |
PE Assets $mlns |
Portfolio |
M&A Activity Buy vs Sell, Last 5 Years |
|
|---|---|---|---|---|
| Total | Current | |||
|
Gilde Healthcare
Utrecht, Netherlands |
2,930 | 62 | 21 |
|
|
Main Capital Partners
The Hague, Netherlands |
6,761 | 70 | 32 |
|
|
Holland Capital
Amsterdam, Netherlands |
563 | 51 | 41 |
|
|
Avedon Capital Partners
Amsterdam, Netherlands |
- | 38 | 16 |
|
|
Icos Capital
Rotterdam, Netherlands |
- | 17 | 10 |
|
|
EQT Life Sciences
Amsterdam, Netherlands |
3,944 | 48 | 36 |
|
|
5square
Laren, Netherlands |
- | 16 | 10 |
|
|
Capital A
Amsterdam, Netherlands |
- | 118 | 40 |
|
|
Écart Invest
Den Haag, Netherlands |
- | 33 | 9 |
|
|
TIIN Capital
Naarden, Netherlands |
- | 17 | 12 |
|
|
Ramphastos Investments
Rhenen, Netherlands |
1,000 | 11 | 9 |
|
|
Axivate Capital
Amsterdam, Netherlands |
- | 26 | 14 |
|
|
Prime Ventures (VC)
Amsterdam, Netherlands |
845 | 38 | 12 |
|
|
Rabo Private Equity
Utrecht, Netherlands |
563 | 34 | 2 |
|
|
Newion Partners B.V.
Amsterdam, Netherlands |
- | 34 | 7 |
|
|
Esperante
Hoofddorp, Netherlands |
- | 1 | - |
|
Mergr was built to make it easier to research private equity firms, their investments, and who they buy from and sell to.
Behind each firm is a strategy, and Mergr gives professionals structured access to firm profiles, portfolio companies, and investment history across the private equity landscape.
The platform is powerful but easy to use — so you can quickly identify the right firms and focus on qualified opportunities.
Full access to Mergr's investor, acquirer, and transaction data starts here.